ATE396253T1 - Verfahren zur herstellung einer undifferenzierten zell - Google Patents

Verfahren zur herstellung einer undifferenzierten zell

Info

Publication number
ATE396253T1
ATE396253T1 AT96901432T AT96901432T ATE396253T1 AT E396253 T1 ATE396253 T1 AT E396253T1 AT 96901432 T AT96901432 T AT 96901432T AT 96901432 T AT96901432 T AT 96901432T AT E396253 T1 ATE396253 T1 AT E396253T1
Authority
AT
Austria
Prior art keywords
producing
undifferentiated cell
undifferentiated
cell
Prior art date
Application number
AT96901432T
Other languages
English (en)
Inventor
Ilham Abuljadayel
Original Assignee
Tristem Trading Cyprus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tristem Trading Cyprus Ltd filed Critical Tristem Trading Cyprus Ltd
Application granted granted Critical
Publication of ATE396253T1 publication Critical patent/ATE396253T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96901432T 1995-02-02 1996-01-31 Verfahren zur herstellung einer undifferenzierten zell ATE396253T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502022.8A GB9502022D0 (en) 1995-02-02 1995-02-02 A method for preparing lymphohaematopoietic progenitor cells

Publications (1)

Publication Number Publication Date
ATE396253T1 true ATE396253T1 (de) 2008-06-15

Family

ID=10768971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901432T ATE396253T1 (de) 1995-02-02 1996-01-31 Verfahren zur herstellung einer undifferenzierten zell

Country Status (23)

Country Link
US (3) US6090625A (de)
EP (1) EP0807166B1 (de)
JP (4) JPH10513053A (de)
KR (1) KR100630591B1 (de)
CN (1) CN1289660C (de)
AP (1) AP693A (de)
AT (1) ATE396253T1 (de)
AU (1) AU4545196A (de)
BR (1) BR9606866A (de)
CA (1) CA2211147C (de)
CY (1) CY2206B1 (de)
DE (1) DE69637534D1 (de)
DK (1) DK0807166T3 (de)
ES (1) ES2308774T3 (de)
GB (1) GB9502022D0 (de)
HK (1) HK1017710A1 (de)
IL (2) IL139244A (de)
NZ (1) NZ300650A (de)
PT (1) PT807166E (de)
RU (2) RU2177996C2 (de)
SI (1) SI0807166T1 (de)
WO (1) WO1996023870A1 (de)
ZA (1) ZA96727B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US9068164B1 (en) 1995-02-02 2015-06-30 Tristem Trading (Cyprus) Limited Method of preparing an undifferentiated cell
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
CA2852534A1 (en) * 1999-08-05 2001-02-15 Abt Holding Company Multipotent adult stem cells and methods for isolation
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
CN100390264C (zh) * 2000-05-10 2008-05-28 特里施泰姆贸易(塞浦路斯)有限公司 一种设备
EP1367899A4 (de) * 2001-02-14 2004-07-28 Leo T Furcht Multipotente adulte stammzellen, ausgangsmaterial dafür, verfahren zu ihrer gewinnung und erhaltung, differenzierungsmethoden dafür, verfahren zu ihrer verwendung, sowie von ihnen stammende zellen
DE10144326B4 (de) * 2001-09-10 2005-09-22 Siemens Ag Verfahren und System zur Überwachung eines Reifenluftdrucks
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
DE10231655A1 (de) * 2002-07-12 2004-02-26 Blasticon Biotechnologische Forschung Gmbh Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung
AU2003298016A1 (en) 2002-11-27 2004-06-23 Regents Of The University Of Minnesota Homologous recombination in multipotent adult progenitor cells
RU2346041C2 (ru) * 2003-07-11 2009-02-10 Бластикон Биотехнологише Форшунг Гмбх Аутологичные клетки моноцитарного происхождения, индуцирующие аутотолерантность, и их применение в фармацевтических препаратах
DE602004024312D1 (de) * 2003-08-12 2010-01-07 Tigenix Nv Verwendung von cxcl6 chemokin bei der prävention oder reparatur von knorpeldefekten
JP2007513188A (ja) 2003-12-04 2007-05-24 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ リソソーム蓄積症の処置のための組成物および方法
WO2006047743A2 (en) * 2004-10-26 2006-05-04 Regents Of The University Of Minnesota Swine multipotent adult progenitor cells
WO2006086639A1 (en) * 2005-02-10 2006-08-17 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
US20080317740A1 (en) * 2005-05-05 2008-12-25 Bruce Blazar Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells
AU2005331534B2 (en) * 2005-05-05 2011-12-08 Regents Of The University Of Minnesota Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues
US20080194024A1 (en) * 2005-07-29 2008-08-14 Mays Robert W Culture of Non-Embryonic Cells at High Cell Density
WO2007047509A2 (en) 2005-10-14 2007-04-26 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
AU2007321928A1 (en) * 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
EP2245141B1 (de) * 2008-01-18 2018-03-14 Regents of the University of Minnesota Stammzellenaggregate und verfahren zur herstellung und verwendung
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
CN103087991B (zh) 2009-06-05 2018-06-12 富士胶片细胞动力公司 重编程t细胞和造血细胞的方法
JP6243119B2 (ja) * 2009-07-21 2017-12-06 エイビーティー ホールディング カンパニー 白血球溢出を低下させる幹細胞の使用
ES2690199T3 (es) * 2009-07-21 2018-11-19 Abt Holding Company Uso de células madre para reducir la extravasación de leucocitos
KR101667834B1 (ko) * 2009-09-15 2016-10-20 고쿠리츠다이가쿠호우진 도쿄다이가쿠 분화 세포의 신규 제조법
CN102647989A (zh) * 2009-10-19 2012-08-22 特里施泰姆贸易(塞浦路斯)有限公司 采用重编程序的成熟成体细胞的治疗
WO2011106476A1 (en) * 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
SG10201503700WA (en) 2010-05-12 2015-06-29 Abt Holding Co Modulation of splenocytes in cell therapy
WO2011158125A2 (en) 2010-06-17 2011-12-22 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
AU2011293440B2 (en) 2010-08-24 2016-05-05 Katholieke Universiteit Leuven Non-static suspension culture of cell aggregates
CN112048466A (zh) * 2012-04-24 2020-12-08 细胞疗法有限责任公司 从头生成多能细胞
RU2497947C1 (ru) * 2012-08-15 2013-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства зравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) Способ модификации моноцитов периферической крови для повышения их паракринной активности при аутологической трансплантации
SG11201508403XA (en) 2013-04-12 2015-11-27 Saverio Lafrancesca Improving organs for transplantation
AU2016387339B2 (en) 2016-01-21 2022-11-17 Abt Holding Company Stem cells for wound healing
JP2017008049A (ja) * 2016-07-04 2017-01-12 トライステム・トレイディング・（キプロス）・リミテッドＴｒｉＳｔｅｍ Ｔｒａｄｉｎｇ （Ｃｙｐｒｕｓ） Ｌｉｍｉｔｅｄ 再プログラム化成熟成体細胞を用いる治療
US20220125852A1 (en) * 2020-10-27 2022-04-28 Therapeutic Solutions International, Inc. Protection and regeneration of neurological function by using stem cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004681B1 (en) * 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US6194376B1 (en) * 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
JPH07505045A (ja) * 1991-11-22 1995-06-08 ザ ジェネラル ホスピタル コーポレイション 移植における特異的寛容
WO1993025216A1 (en) * 1992-06-08 1993-12-23 Becton, Dickinson And Company Human primitive stem cells
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren
US5654186A (en) * 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
GB9502022D0 (en) * 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
US6227202B1 (en) * 1996-09-03 2001-05-08 Maulana Azad Medical College Method of organogenesis and tissue regeneration/repair using surgical techniques
US6468794B1 (en) * 1999-02-12 2002-10-22 Stemcells, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use

Also Published As

Publication number Publication date
DE69637534D1 (de) 2008-07-03
US20110143431A1 (en) 2011-06-16
IL139244A (en) 2006-10-05
JPH10513053A (ja) 1998-12-15
CA2211147C (en) 2012-01-17
EP0807166B1 (de) 2008-05-21
KR19980701949A (ko) 1998-06-25
JP2012040011A (ja) 2012-03-01
HK1017710A1 (en) 1999-11-26
MX9705919A (es) 1997-10-31
IL116994A (en) 2001-01-11
CN1180374A (zh) 1998-04-29
AP693A (en) 1998-11-11
SI0807166T1 (sl) 2008-12-31
DK0807166T3 (da) 2008-09-22
CA2211147A1 (en) 1996-08-08
ZA96727B (en) 1996-08-16
BR9606866A (pt) 1997-12-23
US6090625A (en) 2000-07-18
PT807166E (pt) 2008-08-27
JP2007259868A (ja) 2007-10-11
KR100630591B1 (ko) 2007-04-11
JP2009148266A (ja) 2009-07-09
EP0807166A1 (de) 1997-11-19
CY2206B1 (en) 2002-11-08
RU2177996C2 (ru) 2002-01-10
WO1996023870A1 (en) 1996-08-08
US20020076812A1 (en) 2002-06-20
AP9701031A0 (en) 1997-07-31
AU4545196A (en) 1996-08-21
GB9502022D0 (en) 1995-03-22
RU2215539C2 (ru) 2003-11-10
CN1289660C (zh) 2006-12-13
NZ300650A (en) 1999-04-29
ES2308774T3 (es) 2008-12-01

Similar Documents

Publication Publication Date Title
ATE396253T1 (de) Verfahren zur herstellung einer undifferenzierten zell
DE69723724D1 (de) Verfahren zur herstellung von polyurethan-peo-heparin-beschichtungen
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE59607727D1 (de) Verfahren zur herstellung einer festwertspeicherzellenanordnung
DE69512888T2 (de) Verfahren zur herstellung von alkoholen
DE69516188D1 (de) Verfahren zur herstellung von therephthalsäure
DE69602331T2 (de) Verfahren zur herstellung von polyolefin
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69602166D1 (de) Verfahren zur herstellung von methanol
DE69604277T2 (de) Verfahren zur herstellung von nootkaton
DE69717974D1 (de) Verfahren zur herstellung von ganciclovirderivaten
DE59610504D1 (de) Verfahren zur herstellung von polymerelektrolyten
DE69520945D1 (de) Verfahren zur herstellung von purinen
DE69606871T2 (de) Verfahren zur herstellung überzogener gegenstände
DE69821428D1 (de) Verfahren zur herstellung einer alpha-monoglucosylhesperidin-reichen substanz
DE69706828T2 (de) Verfahren zur herstellung von purinderivaten
DE59706513D1 (de) Verfahren zur herstellung einer dram-zellenanordnung
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE69608442D1 (de) Verfahren zur herstellung von 5-formylvelerionsäure
DE69615836D1 (de) Verfahren zur herstellung von boroxyd
DE69616285D1 (de) Verfahren zur herstellung von einer akustischen linienanordnung
DE59601772D1 (de) Verfahren zur herstellung einer elektrischen glühlampe
DE69608811D1 (de) Verfahren zur herstellung von heptafluorpropan
DE69609499T2 (de) Verfahren zur herstellung von streptograminen
DE59608270D1 (de) Verfahren zur herstellung strukturfester papiere

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0807166

Country of ref document: EP